CELLMED (셀메드)

Cellmed Orthocellular Medicine and Pharmaceutical Association (셀메드 세포교정의약학회)
권호 표지
DOI QR코드

DOI QR Code

A Case study on improvement of ICE syndrome using Ortho-Cellular Nutrition Therapy (OCNT)

세포교정영양요법(OCNT)을 이용한 ICE 증후군 개선 사례 연구

  • Received : 2024.02.29
  • Accepted : 2024.02.29
  • Published : 2024.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: A Case study on improvement of ICE syndrome through the use of OCNT. Methods: OCNT was performed on a 45-year-old Korean female who had difficulty in opening the eyes widely due to painful and xerophthalmias, and suffered inconvenience in daily life due to myodesopsia. Results: After the implementation of OCNT, the intraocular pressure (IOP) level was restored to normal, and the pain, dryness and myodesopsia symptoms were alleviated. This resulted in improvement in depressive symptoms and quality of life. Conclusion: For patients suffering from problems such as elevated intraocular pressure, myodesopsia, and xerophthalmia, OCNT can be helpful in improvement and treatment of symptoms.

Keywords

References

  1. Quigley, H. A. & Forster, R. F. J. A. o. o. Histopathology of cornea and iris in Chandler's syndrome. 96, 1878-1882 (1978). 
  2. Nomi, Y., Iwasaki-Kurashige, K. & Matsumoto, H. J. M. Therapeutic effects of anthocyanins for vision and eye health. 24, 3311 (2019). 
  3. Kizawa, Y. et al. Effects of anthocyanin, astaxanthin, and lutein on eye functions: a randomized, double-blind, placebo-controlled study. 69, 77-90 (2021). 
  4. Bourne, W. M., Nelson, L. R., Hodge, D. O. J. I. o. & science, v. Central corneal endothelial cell changes over a ten-year period. 38, 779-782 (1997). 
  5. Bourne, W. J. E. Biology of the corneal endothelium in health and disease. 17, 912-918 (2003). 
  6. Kim, D. K., Sim, B. R., Kim, J. I., Khang, G. J. C. & Biointerfaces, S. B. Functionalized silk fibroin film scaffold using β-Carotene for cornea endothelial cell regeneration. 164, 340-346 (2018). 
  7. Hynnekleiv, L. et al. Hyaluronic acid in the treatment of xerophthalmia disease. 100, 844-860 (2022). 
  8. Kim, Y., Moon, C. H., Kim, B.-Y. & Jang, S. Y. J. J. o. o. Oral hyaluronic acid supplementation for the treatment of xerophthalmia disease: a pilot study. 2019 (2019). 
  9. Macsai, M. S. J. T. o. t. A. O. S. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). 106, 336 (2008). 
  10. Lin, T. et al. The efficacy and safety of YAG laser vitreolysis for symptomatic vitreous floaters of complete PVD or non-PVD. 1-14 (2022). 
  11. Schulz-Key, S., Carlsson, J. O. & Crafoord, S. J. A. O. Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. 89, 159-165 (2011). 
  12. Shui, Y.-B. et al. The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear cataracts. 127, 475-482 (2009). 
  13. Konerirajapuram, N. S. et al. Trace elements iron, copper and zinc in vitreous of patients with various vitreoretinal diseases. 52, 145-148 (2004). 
  14. Sato, M. & Kondoh, M. J. T. T. j. o. e. m. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. 196, 9-22 (2002). 
  15. Ankamah, E. et al. Dietary intervention with a targeted micronutrient formulation reduces the visual discomfort associated with vitreous degeneration. 10, 19-19 (2021).